Creating Next Generation Smart Cell Therapies: Outpace Bio Receives $30 Million in Series A Funding Led by ARTIS Ventures and Lyell Immunopharma Inc.

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3cFlUW0
via IFTTT